Tag: Exact Sciences
-
Exact Sciences Launches the Cologuard™ Plus Test, Transforming Colorectal Cancer Screening
The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Madison, Wis., […]
-
New Evidence Validates ONCODETECT’S™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
Results from prospective molecular residual disease (MRD) study show a positive Oncodetect test result is strongly associated with recurrence in stage III colon cancer patients Oncodetect test achieved the primary endpoint in a second clinical validation study, extending its prognostic value into stages […]
-
Exact Sciences and PGA Tour Champions extend long-running partnership in Tucson
Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company […]
-
Meet Exact Sciences: The PBC company behind Cologuard
Exact Sciences joined the Phoenix Bioscience Core when it acquired a pair of Phoenix-based startups from the Translational Genomics Research Institute (TGen) and the International Genomics Consortium. The Wisconsin-based company […]
-
Exact Sciences awards grants to health centers focused on improving cancer screenings in vulnerable populations
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today awarded $525,000 in grants to eight federally qualified health centers focused on improving colorectal cancer screening rates in vulnerable populations, including Mountain Park Health Center in Phoenix.
-
Exact Sciences presents new data on biomarkers in the blood that can signal for cancer
Exact Sciences recently presented new data from a multi-cancer early detection biomarker validation study that showed the performance of four biomarkers found in the blood that can signal the presence of cancer in the body.
